长非编码RNA
PI3K/AKT/mTOR通路
癌症研究
癌症
信号转导
生物
DNA甲基化
癌变
核糖核酸
细胞生物学
小RNA
生物信息学
计算生物学
基因
基因表达
遗传学
作者
Wen Xu,Bei Wang,Yuxuan Cai,Jinlan Chen,Xing Lv,Chong Guo,Chengfu Yuan
标识
DOI:10.2174/1381612827666210325105106
摘要
Background: Long non-coding RNAs (lncRNA) have been identified as novel molecular regulators in cancers. LncRNA ADAMTS9-AS2 can mediate the occurrence and development of cancer through various ways, such as regulating miRNAs, activating the classical signaling pathways in cancer, and so on, which have been studied by many scholars. In this review, we summarize the molecular mechanisms of ADAMTS9-AS2 in different human cancers. Methods: Through a systematic search of PubMed, lncRNA ADAMTS9-AS2 mediated molecular mechanisms in cancer are summarized inductively. Results: ADAMTS9-AS2 aberrantly expression in different cancers is closely related to cancer proliferation, invasion, migration, and inhibition of apoptosis. The involvement of ADAMTS9-AS2 in DNA methylation, mediating PI3K / Akt / mTOR signaling pathways, and regulating miRNAs and proteins, shows its significant potential as a therapeutic cancer target. Conclusion: LncRNA ADAMTS9-AS2 can become a promising biomolecular marker and a therapeutic target for human cancer.
科研通智能强力驱动
Strongly Powered by AbleSci AI